Showing 1071-1080 of 2192 results for "".
Pharmacotherapy for Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pharmacotherapy-for-parkinson-disease/32038/The medical management of Parkinson disease remains the same despite the increasingly complex treatment landscape: maximize function and minimize side effects.Neuromuscular Notes: Next Generation Treatments for Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-next-generation-treatments-for-myasthenia-gravis/31666/Complement inhibitors, FcRn antagonists, and B-cell targeted therapies increase treatment options for MG but do not replace existing immunosuppressive therapies.Atypical Parkinsonian Syndromes
https://practicalneurology.com/diseases-diagnoses/movement-disorders/atypical-parkinsonian-syndromes/31933/Awareness of red flags and key examination findings speeds diagnosis.Cluster Headache Acute Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/cluster-headache-acute-therapies/31521/Despite strong evidence for high-flow oxygen, subcutaneous sumatriptan, and zolmitriptan nasal spray, patients often receive less-than-adequate abortive treatment.Alzheimer’s Disease Drug Development & Emerging Therapies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/alzheimers-disease-drug-development-emerging-therapies/31541/We must all work together to accelerate clinical trials and create meaningful new therapies for Alzheimer’s disease.Multiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.Cluster Headache and Other Trigeminal Autonomic Cephalalgias
https://practicalneurology.com/diseases-diagnoses/headache-pain/cluster-headache-and-other-trigeminal-autonomic-cephalalgias/32001/Accurate and timely classification of cluster headache vs other TACs can help speed time to relief and remission in those with headache pain.Headache Horizons: Key Updates in Headache and Migraine Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/key-updates-in-headache-and-migraine-care/35529/From gepants to GLP-1 agonists, new therapies and a shift toward early intervention may redefine migraine care and improve quality of life for people with migraine.Recognizing and Responding to Comorbidities in MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/recognizing-and-responding-to-comorbidities-in-ms/30678/MS patients may be at increased risk for certain psychiatric and physical comorbidities. Neurologists can help identify and manage these conditions.Recognize and Prevent Polypharmacy in MS Patients
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/recognize-and-prevent-polypharmacy-in-ms-patients/30836/Minimizing drug-to-drug interactions is paramount in finding an appropriate treatment regimen, ensuring safety, and encouraging good quality of life.